ClinicalTrials.Veeva

Menu

Mortality and Morbidity Associated With New Onset Acute Kidney Injury in Critically Ill COVID-19 Infection Patients

Arrowhead Regional Medical Center logo

Arrowhead Regional Medical Center

Status

Completed

Conditions

Acute Kidney Injury

Study type

Observational

Funder types

Other

Identifiers

Details and patient eligibility

About

This study explored the incidence of morbidity and mortality associated with AKI in critically ill adult patients infected with COVID-19. There are two groups for comparison. Group1. patients were directly admitted to the intensive care unit (ICU) from the emergency department (ED) Group 2. patients were initially managed on the medical floor and later transferred to the ICU for worsening respiratory status. The investigating team evaluated the correlation of inflammatory markers and common risk factors such as obesity, diabetes, hypertension and ethnicity to the development of AKI in the target population. The primary outcome is mortality participants will received their regular healthcare in a medical setting

Enrollment

267 patients

Sex

All

Ages

18 to 100 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

positive for SARS-CoV-2 on a real-time polymerase chain reaction test (RT-PCR) upon admission to the hospital

Exclusion criteria

chronic kidney disease end stage renal disease

Trial design

267 participants in 2 patient groups

Group1
Description:
These critically ill patients were directly admitted to the intensive care unit from the emergency department
Group 2
Description:
These critically ill patients were were initially managed on the medical floor and later transferred to the intensive care unit for worsening respiratory status

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems